Table 1.
(a) Precursor polymer characterization by GPCa
| ||||
---|---|---|---|---|
sample | monomer | Mn. Target g mol−1 | GPC Mn g mol−1 | Mw/Mn |
Methyl_3k | methyl | 3000 | 11 200 | 1.08 |
Ethyl_3k | ethyl | 3000 | 9200 | 1.10 |
Propyl_3k | propyl | 3000 | 9200 | 1.10 |
Butyl_3k | butyl | 3000 | 11 500 | 1.08 |
Isopentyl_3k | isopentyl | 3000 | 11 400 | 1.11 |
Hexyl_3k | hexyl | 3000 | 11 000 | 1.08 |
Methyl_10k | methyl | 10 000 | 49 000 | 1.05 |
Ethyl_10k | ethyl | 10 000 | 11 300 | 1.10 |
Propyl_10k | propyl | 10 000 | 28 200 | 1.07 |
Butyl_10k | butyl | 10 000 | 26 700 | 1.07 |
Isopentyl_8k | isopentyl | 8000 | 22 600 | 1.06 |
Isopentyl_10k | isopentyl | 10 000 | 51 500 | 1.16 |
Hexyl_10k | hexyl | 10 000 | 27 600 | 1.04 |
(b) Characterization of the antimicrobial homopolymers by biological assaysb
| |||||
sample | MIC90
μg mL−1
|
HC50 μg mL−1 | selectivty
|
||
E. coli | S. aureus | E. coli | S. aureus | ||
| |||||
Methyl_3k | >200 | 100 | 2000 | <10 | 20 |
Ethyl_3k | 50 | 50 | 1400 | 28 | 28 |
Propyl_3k | 6.25 | 15 | 50 | 8.3 | 3.3 |
Butyl_3k | 15 | 25 | <50 | <3.3 | <2.0 |
Isopentyl_3k | 12.5 | 50 | <50 | <4.0 | <1.0 |
Hexyl_3k | >200 | >200 | <50 | <0.3 | <0.3 |
Methyl_10k | >200 | >200 | 50 | <10 | <10 |
Ethyl_10k | >200 | >200 | 1250 | <6.3 | <6.3 |
Propyl_10k | 3.75 | 200 | <50 | 13 | <0.25 |
Butyl_10k | 20 | >200 | <50 | <2.5 | <0.3 |
Isopentyl_8k | 50 | >200 | <50 | <0.3 | <0.3 |
Isopentyl_10k | 50 | 200 | <50 | <0.3 | <0.3 |
Hexyl_10k | 100 | >200 | n.d. | n.d. | n.d. |
DMF, 0.01 mol L−1 LiCl, PS standards.
Inhibitory activity towards bacterial growth of E. coli and S. aureus bacteria. (MIC90 = minimal inhibitory concentration preventing 90% bacterial growth) and hemolytic activity towards red blood cells (HC50 = concentration lysing 50% of blood cells).